Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.

about

Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.

Item

http://www.wikidata.org/entity/Q38863215

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Hypertrophic Cardiomyopathy: N ...... n Heart Association Guideline.

@en

type

Item

label

Hypertrophic Cardiomyopathy: N ...... n Heart Association Guideline.

@en

prefLabel

Hypertrophic Cardiomyopathy: N ...... n Heart Association Guideline.

@en

P1476

Hypertrophic Cardiomyopathy: N ...... n Heart Association Guideline.

@en

P2093

Andrew Wang

http://www.w3.org/2001/XMLSchema#string

Ariane Fraiche

http://www.w3.org/2001/XMLSchema#string

P2860

New perspectives on the prevalence of hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy.

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.

Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial.

P2888

s11886-016-0751-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-016-0751-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038446762

http://www.w3.org/2001/XMLSchema#string

P698

27294414

http://www.w3.org/2001/XMLSchema#string